日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nasal Foralumab for the Treatment of Progression Independent of Relapses in Patients With Nonactive Secondary Progressive Multiple Sclerosis

鼻用福鲁单抗治疗非活动性继发进展型多发性硬化症患者的疾病进展(与复发无关)

Sahyouni, Ronald; Mahmoodi, Amin; Mahmoodi, Amir; Rajaii, Ramin R; Hasjim, Bima J; Bustillo, David; Huang, Melissa; Tran, Diem Kieu; Chen, Jefferson W; Chitnis, Tanuja; Singhal, Tarun; Zurawski, Jonathan; Saraceno, Taylor J; Gopalakrishnan, Niveditha; Cain, Lauren; LaBarre, Brenna; King, Devin; Bergmark, Regan W; Maxfield, Alice Z; Cicero, Steven; Pan, Hong; Dubey, Shipra; Vaquerano, Steven; Hansel, Caleb; Healy, Brian C; Saxena, Shrishti; Lokhande, Hrishikesh A; Baharnoori, Moogeh; Madill, Evan Samuel; Sheth, Manali S; Rodin, Rachel; Ye, Jessica; Clementi, Nancy; Clementi, William A; Weiner, Howard L

Advances in the management of ocular anterior segment diseases using biomaterials-based drug delivery systems

利用生物材料药物递送系统治疗眼部前段疾病的进展

Subhash, Nayana E; Prabhu, Meghana; Hazarika, Manali; S, Shailaja; Bhandary, Sulatha V; Guru, Bharath Raja

Phase IB study of Avelumab and whole brain radiotherapy in patients with leptomeningeal disease from solid tumors: Results and molecular analyses

Avelumab联合全脑放疗治疗实体瘤软脑膜转移患者的IB期研究:结果和分子分析

Piña, Yolanda; Law, Vincent; Sahebjam, Solmaz; Tran, Nam; Siddarajappa, Navya; Li, Jiannong; Mo, Qianxing; Phadke, Manali S; Arrington, John; Macaulay, Robert; Mokhtari, Sepideh; Evernden, Brittany; Ahmed, Kamran A; Smalley, Inna; Yu, Michael; Smalley, Keiran S M; Forsyth, Peter A

Identification of anti-TIM-3 based checkpoint inhibitor combinations with activity in immunotherapy refractory melanoma models

鉴定在免疫疗法难治性黑色素瘤模型中具有活性的基于抗TIM-3的检查点抑制剂组合

Manali S Phadke ,Jiannong Li ,Sathya Sriramareddy ,Paulo C Rodriguez ,Brian Ruffell ,Vincent C Luca ,Thuy T T Tran ,Yian Ann Chen ,Keiran S M Smalley

RAS(ON) multi-selective inhibition drives antitumor immunity in preclinical models of NRAS-mutant melanoma

RAS(ON)多选择性抑制驱动NRAS突变型黑色素瘤临床前模型中的抗肿瘤免疫

Larissa Anastacio Da Costa Carvalho ,Nataliya Tovbis Shifrin ,Manali S Phadke ,Michael F Emmons ,Ximo Pechuan-Jorge ,Felix Mbuga ,Oscar E Ospina ,Christopher Chow ,Lillian Seu ,Olivia L Rose ,Aparna Hegde ,Nikhil I Khushalani ,Elsa Quintana ,Keiran S M Smalley

A 79-Year-Old Woman With Worsening Headaches and Pachymeningeal Enhancement: A Case Report From the National Multiple Sclerosis Society Case Conference Proceedings

一名79岁女性,头痛加剧并伴有硬脑膜强化:来自美国国家多发性硬化症协会病例研讨会的病例报告

Sheth, Manali S; Hale, David E; Mcarthur, Justin C; Zamvil, Scott S; Goldman, Myla D; Riley, Claire; Chitnis, Tanuja

An Engineered Mouse Model That Generates a Diverse Repertoire of Endogenous, High-Affinity Common Light Chain Antibodies

一种可产生多种内源性、高亲和力的共同轻链抗体的工程小鼠模型

Yinghui Rong, I-Ling Chen, Lance Larrabee, Manali S Sawant, Germaine Fuh, Patrick Koenig

C19MC miRNA-520G induces SP100 antiviral gene transcription and inhibits melanin production in skin cutaneous melanoma

C19MC miRNA-520G 诱导 SP100 抗病毒基因转录并抑制皮肤黑色素瘤中的黑色素生成

Jinesh, Goodwin G; Smallin, Marian T; Mtchedlidze, Nino; Godwin, Isha; Napoli, Marco; Hackel, Nicole; Phadke, Manali S; Deshpande, Avani A; Li, Xiaobo; Lockhart, John H; Baldwin, Jaden R; Acevedo-Acevedo, Suehelay; Gao, Yifeng; Reiser, Michelle A; Smalley, Keiran S M; Flores, Elsa R; Brohl, Andrew S

Targeting NRAS Mutations in Advanced Melanoma

靶向治疗晚期黑色素瘤中的NRAS突变

Phadke, Manali S; Smalley, Keiran S M

Differential requirements for CD4+ T cells in the efficacy of the anti-PD-1+LAG-3 and anti-PD-1+CTLA-4 combinations in melanoma flank and brain metastasis models

在黑色素瘤侧腹和脑转移模型中,抗PD-1+LAG-3和抗PD-1+CTLA-4联合疗法的疗效对CD4+ T细胞的需求存在差异

Manali S Phadke ,Jiannong Li ,Zhihua Chen ,Paulo C Rodriguez ,Jessica K Mandula ,Lilit Karapetyan ,Peter A Forsyth ,Y Ann Chen ,Keiran S M Smalley